Sanofi Taxotere Patents Ruled Invalid In Hospira Spat
A federal judge has invalidated two patents for Sanofi-Aventis SA's flagship cancer treatment Taxotere, paving the way for rival Hospira Inc. to bring a generic version of the drug to the...To view the full article, register now.
Already a subscriber? Click here to view full article